Close Menu

NEW YORK (GenomeWeb) – NanoString today said that its preliminary financial results for the fourth quarter and fiscal year ended December 31, 2018 are expected to beat its previously stated guidance, as well as the consensus Wall Street estimates.

NanoString said that product and service revenue is expected to be approximately $23.5 million for the fourth quarter of 2018, which would exceed the firm's previous guidance range of $22 to $23 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.